A Study to Investigate the Safety, Tolerability, Immunogenicity, and Pharmacodynamics of VXX-401 Administered IM in Adult Participants
Clinical trial NCT05762276 · UNKNOWN
Trial details
- NCT number
- NCT05762276
- Sponsor
- Vaxxinity, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-07
- Primary completion
- 2024-06-27
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.